Jaime Gallego Perez-Larraya

10PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 26, 2026
Feasibility and Safety of Autologous Dendritic Cell Vaccination Combined with Radio-Chemotherapy in Newly Diagnosed Glioblastoma: A Retrospective Single-Center Series.

Inés Esparragosa Vázquez, Ascensión López-Díaz de Cerio, Susana Inoges

|Mar 13, 2024
Dendritic Cells in Cancer Immunology and Immunotherapy.

Laura Hato, Angel Vizcay, Iñaki Eguren

|Feb 25, 2022
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies.

Adam D Cohen, Samir Parekh, Bianca D Santomasso

|Feb 14, 2022
Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort.

Emilie Le Rhun, Patrick Devos, Sebastian Winklhofer

|Dec 30, 2020
Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET.

Marc Garcia-Moure, Marisol Gonzalez-Huarriz, Sara Labiano

|Jun 07, 2019
Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.

Paola Anna Jablonska, Ricardo Diez-Valle, Jaime Gállego Pérez-Larraya

Pageof 2

Frequent Collaborators

4 joint publications

Marta Zalacain

2 joint publications

Jose L Perez-Gracia

2 joint publications

Erin Lee

2 joint publications

Kevin C De Braganca